6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors
Details for Australian Patent Application No. 2005288045 (hide)
International Classifications
Event Publications
17 May 2007 PCT application entered the National Phase
PCT publication WO2006/036015 Priority application(s): WO2006/036015
29 May 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 29 Jan 2008
2 October 2008 Alteration of Name
The name of the applicant has been altered to Sanofi-Aventis; Mitsubishi Tanabe Pharma Corporation
18 August 2011 Application Accepted
Published as AU-B-2005288045
15 December 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005288059-Impeller for blower and air conditioner having the same
2005288034-Telomelysin-GFP gene-containing recombinant virus
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser